SINGAPORE (Jan 31): A biotech company with offices in Singapore and San Francisco, Engine Biosciences, says it has secured US$10 million ($13.1 million) in seed funding from both American and Asian investors.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

SUBSCRIBE NOW